BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18270980)

  • 1. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
    Tian L; Nikolic-Paterson DJ; Tesch GH
    Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-2 mediates diabetic renal injury.
    Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
    Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a S1PR2 specific
    Jiang H; Huang T; Yu Y; Zhou C; Qiu L; Mai HN; Gropler RJ; Klein RS; Tu Z
    Nucl Med Biol; 2023; 122-123():108370. PubMed ID: 37556928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-deficient HSRA rats exhibit renal injury with age but have limited renal damage from streptozotocin-induced hyperglycemia.
    Cobb MB; Wu W; Attipoe EM; Johnson AC; Garrett MR
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1093-F1105. PubMed ID: 33843272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause.
    Diamond-Stanic MK; Romero-Aleshire MJ; Hoyer PB; Greer K; Hoying JB; Brooks HL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F139-46. PubMed ID: 21048029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R).
    Salvi R; Abderrahmani A
    J Diabetes Res; 2014; 2014():768024. PubMed ID: 24672804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorating effect of probiotics in a rat model of chronic kidney disease.
    Inatomi T; Honma M
    PLoS One; 2023; 18(3):e0281745. PubMed ID: 36996047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Engineered
    Kong Y; Liu Z; Xiao Q; Wu F; Hu L; Deng X; Chen T
    Front Immunol; 2022; 13():905876. PubMed ID: 35734171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.
    Wang J; Wang S; Wang W; Chen J; Zhang Z; Zheng Q; Liu Q; Cai L
    J Cell Mol Med; 2019 Sep; 23(9):6319-6330. PubMed ID: 31270951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.
    Inada A; Inada O; Fujii NL; Nagafuchi S; Katsuta H; Yasunami Y; Matsubara T; Arai H; Fukatsu A; Nabeshima YI
    J Am Soc Nephrol; 2016 Oct; 27(10):3035-3050. PubMed ID: 26940099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging.
    Shepherd DL; Nichols CE; Croston TL; McLaughlin SL; Petrone AB; Lewis SE; Thapa D; Long DM; Dick GM; Hollander JM
    J Mol Cell Cardiol; 2016 Jan; 90():74-83. PubMed ID: 26654913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
    Takahashi T; Harris RC
    J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.
    Merscher S; Pedigo CE; Mendez AJ
    Front Endocrinol (Lausanne); 2014; 5():169. PubMed ID: 25352833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
    Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
    Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice.
    Miao X; Cui W; Sun W; Xin Y; Wang B; Tan Y; Cai L; Miao L; Fu Y; Su G; Wang Y
    Oxid Med Cell Longev; 2013; 2013():879516. PubMed ID: 23589759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
    Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
    Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway.
    Sun L; Kondeti VK; Xie P; Raparia K; Kanwar YS
    Am J Pathol; 2011 Oct; 179(4):1706-18. PubMed ID: 21854750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction as a potential contributor in diabetic nephropathy.
    Nakagawa T; Tanabe K; Croker BP; Johnson RJ; Grant MB; Kosugi T; Li Q
    Nat Rev Nephrol; 2011 Jan; 7(1):36-44. PubMed ID: 21045790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.